Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Postmenopausal osteoporosis
Age: Adult
Dose: Capsule – 0.25 mcg
Frequency: twice daily
Note: Serum creatinine levels should be determined at 4 weeks, 3 and 6 months and 6 monthly intervals thereafter.
Indication: Postmenopausal osteoporosis
Age: Adult
Dose: Capsule – 0.50 mcg
Frequency: once daily
Note: Serum creatinine levels should be determined at 4 weeks, 3 and 6 months and 6 monthly intervals thereafter.

Child Dose

Clinical InformationAdministration Information
Indication: Chronic Renal Dialysis Associated Hypocalcemia
Dose: Oral – 0.25-2 mcg/day
Frequency: once daily
Note: by mouth (oral)
Indication: Hypoparathyroidism/Pseudohypoparathyroidism
Age: less than 1 year
Dose: Oral – 0.04-0.08 mcg/kg
Frequency: once daily
Note: by mouth (oral)
Administration
  • Can be taken with or without food
  • Take with water
Side Effect

Drug Interaction

Drug NameRisk Factors
Magnesium-containing drugs
Hypermagnesaemia may develop in patients on chronic renal dialysis
Digitalis
Hypercalcaemia in patients on digitalis may precipitate cardiac arrhythmias

Disease Interaction

Disease NameRisk Factors
Hypercalcaemia, Evidence of Vitamin D Toxicity
Can worsen calcium levels

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
keep in a dry place away from light and heat. Keep out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.